118 related articles for article (PubMed ID: 15029267)
1. [Therapy of malignant ascites in vivo by 211At-labelled microspheres].
Bredow J; Kretzschmar M; Wunderlich G; Dörr W; Pohl T; Franke WG; Kotzerke J
Nuklearmedizin; 2004 Mar; 43(2):63-8. PubMed ID: 15029267
[TBL] [Abstract][Full Text] [Related]
2. Vascular-targeted radioimmunotherapy with the alpha-particle emitter 211At.
Kennel SJ; Mirzadeh S; Eckelman WC; Waldmann TA; Garmestani K; Yordanov AT; Stabin MG; Brechbiel MW
Radiat Res; 2002 Jun; 157(6):633-41. PubMed ID: 12005541
[TBL] [Abstract][Full Text] [Related]
3. Radioimmunotherapy of nude mice with intraperitoneally growing ovarian cancer xenograft utilizing 211At-labelled monoclonal antibody MOv18.
Andersson H; Lindegren S; Back T; Jacobsson L; Leser G; Horvath G
Anticancer Res; 2000; 20(1A):459-62. PubMed ID: 10769696
[TBL] [Abstract][Full Text] [Related]
4. Alpha-particle radiotherapy with 211At-labeled monodisperse polymer particles, 211At-labeled IgG proteins, and free 211At in a murine intraperitoneal tumor model.
Larsen RH; Hoff P; Vergote IB; Bruland OS; Aas M; De Vos L; Nustad K
Gynecol Oncol; 1995 Apr; 57(1):9-15. PubMed ID: 7705707
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic efficacy of astatine-211-labeled trastuzumab on radioresistant SKOV-3 tumors in nude mice.
Palm S; Bäck T; Claesson I; Danielsson A; Elgqvist J; Frost S; Hultborn R; Jensen H; Lindegren S; Jacobsson L
Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):572-9. PubMed ID: 17869670
[TBL] [Abstract][Full Text] [Related]
6. The curative and palliative potential of the monoclonal antibody MOv18 labelled with 211At in nude mice with intraperitoneally growing ovarian cancer xenografts--a long-term study.
Andersson H; Lindegren S; Bäck T; Jacobsson L; Leser G; Horvath G
Acta Oncol; 2000; 39(6):741-5. PubMed ID: 11130014
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic efficacy of the alpha-emitter 211At bound on microspheres compared with 90Y and 32P colloids in a murine intraperitoneal tumor model.
Vergote I; Larsen RH; de Vos L; Nesland JM; Bruland O; Bjørgum J; Alstad J; Tropé C; Nustad K
Gynecol Oncol; 1992 Dec; 47(3):366-72. PubMed ID: 1473751
[TBL] [Abstract][Full Text] [Related]
8. Distribution of intraperitoneally injected microspheres labeled with the alpha-emitter astatine (211At) compared with phosphorus (32P) and yttrium (90Y) colloids in mice.
Vergote I; Larsen RH; De Vos L; Winderen M; Ellingsen T; Bjørgum J; Hoff P; Aas M; Tropé C; Nustad K
Gynecol Oncol; 1992 Dec; 47(3):358-65. PubMed ID: 1473750
[TBL] [Abstract][Full Text] [Related]
9. 211At radioimmunotherapy of subcutaneous human ovarian cancer xenografts: evaluation of relative biologic effectiveness of an alpha-emitter in vivo.
Bäck T; Andersson H; Divgi CR; Hultborn R; Jensen H; Lindegren S; Palm S; Jacobsson L
J Nucl Med; 2005 Dec; 46(12):2061-7. PubMed ID: 16330571
[TBL] [Abstract][Full Text] [Related]
10. [211At]methylene blue for targeted radiotherapy of human melanoma xenografts: dose fractionation in the treatment of cutaneous tumours.
Link EM; Carpenter RN; Hansen G
Eur J Cancer; 1996 Jun; 32A(7):1240-7. PubMed ID: 8758260
[TBL] [Abstract][Full Text] [Related]
11. Administered activity and metastatic cure probability during radioimmunotherapy of ovarian cancer in nude mice with 211At-MX35 F(ab')2.
Elgqvist J; Andersson H; Bernhardt P; Bäck T; Claesson I; Hultborn R; Jensen H; Johansson BR; Lindegren S; Olsson M; Palm S; Warnhammar E; Jacobsson L
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1228-37. PubMed ID: 17145538
[TBL] [Abstract][Full Text] [Related]
12. 211At-methylene blue for targeted radiotherapy of disseminated melanoma: microscopic analysis of tumour versus normal tissue damage.
Link EM; Michalowski AS; Rösch F
Eur J Cancer; 1996 Oct; 32A(11):1986-94. PubMed ID: 8943686
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the therapeutic efficacy of 211At- and 131I-labelled monoclonal antibody MOv18 in nude mice with intraperitoneal growth of human ovarian cancer.
Andersson H; Palm S; Lindegren S; Bäck T; Jacobsson L; Leser G; Horvath G
Anticancer Res; 2001; 21(1A):409-12. PubMed ID: 11299770
[TBL] [Abstract][Full Text] [Related]
14. [Effects of At-211 alpha irradiation on Ehrlich ascites tumor cells].
Shmakova NL; Norseev IuV; Waĭnson AA; Siuch Z; Fadeeva TA; Fomenkova TE; Khalkin VA; Cherebatenko AP
Eksp Onkol; 1990; 12(3):58-60. PubMed ID: 2111764
[TBL] [Abstract][Full Text] [Related]
15. Animal studies on the in vivo stability of 211At-labelled albumin particles.
Wunderlich G; Henke E; Iwe B; Franke WG; Fischer S; Dreyer R
Nucl Med Commun; 1986 Apr; 7(4):211-4. PubMed ID: 3725235
[TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of transcriptional gene regulation indicates similar physiologic response in mouse tissues at low absorbed doses from intravenously administered 211At.
Langen B; Rudqvist N; Parris TZ; Schüler E; Helou K; Forssell-Aronsson E
J Nucl Med; 2013 Jun; 54(6):990-8. PubMed ID: 23658216
[TBL] [Abstract][Full Text] [Related]
17. [A method for determining the biological effectiveness of ionizing irradiation by evaluation of mitotic depression of Ehrlich-ascites-tumour cells (author's transl)].
Merkle K; Schmidt W
Arch Geschwulstforsch; 1977; 47(2):145-50. PubMed ID: 879982
[TBL] [Abstract][Full Text] [Related]
18. Antitumour activity of mitoxantrone-loaded chitosan microspheres against Ehrlich ascites carcinoma.
Jameela SR; Latha PG; Subramoniam A; Jayakrishnan A
J Pharm Pharmacol; 1996 Jul; 48(7):685-8. PubMed ID: 8866329
[TBL] [Abstract][Full Text] [Related]
19. Intratumour injection of immunoglobulins labelled with the alpha-particle emitter 211At: analyses of tumour retention, microdistribution and growth delay.
Larsen RH; Bruland OS
Br J Cancer; 1998 Apr; 77(7):1115-22. PubMed ID: 9569048
[TBL] [Abstract][Full Text] [Related]
20. The development of a [211At]-astatinated endoradiotherapeutic drug: Part II. Therapeutic results for transplanted adenocarcinoma of the rectum in mice and associated studies.
Brown I; Mitchell JS
Int J Radiat Oncol Biol Phys; 1994 Apr; 29(1):115-24. PubMed ID: 8175418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
